
ESC 2026 marked a turning point — GLP-1s earn their first formal heart failure guideline recommendation and become a cardiometabolic platform.
Discover the 3-phase roadmap to transform pharma reps into confident, credible, and compliant trusted advisors who foster impactful HCP interactions.